National Bank Of Canada Theratechnologies Inc. Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$0.78 - $1.01 $19,110 - $24,745	24,500 Added 4.72%	543,034 $456,000
Q1 2023 Apr 12, 2023	SELL	$0.72 - $1.12 $2,052 - $3,192	-2,850 Reduced 0.55%	518,534 $420,000
Q4 2022 Jan 24, 2023	BUY	$0.83 - $8.04 $233,597 - $2.26 Million	281,443 Added 117.3%	521,384 $0
Q3 2022 Oct 13, 2022	SELL	$1.98 - $2.42 $46,945 - $57,378	-23,710 Reduced 8.99%	239,941 $561,000
Q2 2022 Jul 28, 2022	SELL	$2.21 - $2.7 $7,293 - $8,910	-3,300 Reduced 1.24%	263,651 $588,000
Q1 2022 May 05, 2022	SELL	$2.37 - $3.24 $8,769 - $11,988	-3,700 Reduced 1.37%	266,951 $636,000
Q4 2021 Jan 24, 2022	BUY	$2.92 - $3.76 $790,300 - $1.02 Million	270,651 New	270,651 $815,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $117M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.